Ferrous heme (Fe2+-heme) (Fe2+-heme)

Ferrous heme (Fe2+-heme) is a critical metabolic byproduct generated within the acidic digestive vacuole of the malaria parasite, Plasmodium falciparum, during the proteolysis of host hemoglobin (PubMed: 17221213). Because free heme is highly toxic to the parasite—causing lipid peroxidation and membrane disruption—the parasite must detoxify it by sequestering it into chemically inert crystals known as hemozoin or malaria pigment (PubMed: 8662552). This detoxification pathway is a primary pharmacological target; quinoline-based drugs like chloroquine bind to heme intermediates, preventing their incorporation into hemozoin and leading to the accumulation of toxic heme-drug complexes that kill the parasite. Furthermore, Fe2+-heme plays a unique role in the activation of artemisinin and its derivatives. The ferrous iron center of the heme molecule reacts with the drug's endoperoxide bridge, triggering a reductive cleavage that generates highly reactive carbon-centered radicals (PubMed: 12165161). These radicals subsequently alkylate essential parasite proteins and lipids, leading to rapid parasite death. Consequently, Fe2+-heme serves as both a metabolic vulnerability and a chemical trigger for the most potent antimalarial agents currently in clinical use.

Other names

Ferroprotoporphyrin IXFree hemeHeme bIron(II)-protoporphyrin IXUnsequestered heme

Inhibition of heme biocrystallization into hemozoin and the reductive activation of endoperoxide-containing antimalarials to generate cytotoxic free radicals.